Antigens linked to synthetic microspheres induce immune responses in primates in the absence of adjuvant

Immunobiology

Volumn 195, Issue 1, 1996, Pages 105-118

  Sedlik, Christine ^a   Perraut, Ronald ^b,c   Bonnemains, Bernard ^b   Leclerc, Claude ^a  

^a INSTITUT PASTEUR   (France)

^b INSTITUT PASTEUR DE LA GUYANE   (French Guiana)

^c INSTITUT PASTEUR DE DAKAR   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; ANTIGEN; IMMUNOGLOBULIN; IMMUNOLOGICAL ADJUVANT; MICROSPHERE; MONOCLONAL ANTIBODY; PEPTIDE; PROTEIN; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CEBIDAE; CONTROLLED STUDY; COVALENT BOND; DRUG FORMULATION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOPOTENTIATION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; VACCINATION;

EID: 0030061581     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(96)80009-X     Document Type: Article

References (27)

1. LECLERC, C., and F. R. VOGEL. 1986. Synthetic immunomodulators and synthetic vaccines. In: CRC Critical Reviews in Therapeutic Drug Carrier Systems. CRC Press, Inc., pp. 353.
2. HUI, G. S. N., L. Q. TAM, S. P. CHANG, S. E. CASE, C. HASHIRO, and W. A. SIDDIQUI. 1991. Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund's complete adjuvant in inducing growth inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp 195. Infect. Immun. 59: 1585.
3. KURA, U., D. PYE, R. LORD, C. PAM, H. GOULD, and M. GEYSEN. 1989. Immune response to a synthetic peptide corresponding to an epitope of a parasitophorous vacuole membrane antigen from P. falciparum. J. Immunol. 143: 1334.
4. ALLISON, A. C., and N. E. BYARS. 1986. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell mediated immunity. J. Immunol. Methods 95: 157.
5. GALELLI, A., B. CHARLOT, E. DERIAUD, and C. LECLERC. 1993. B cells do not present antigen covalently linked to microspheres. Immunol. 79: 69.
6. + T cell responses by antigens covalently linked to synthetic microspheres does not require adjuvant. Int. Immunol. 7: 45.
7. GARRAUD, O. 1992. The squirrel monkey Saimiri sciureus: an experimental model for immunological studies on human pathogens. Med. Sci. Res. 20: 3.
8. GARRAUD, O., J.-P. POINGT, R. PERRAUT, and J. GYSIN. 1989. Peripheral blood mononuclear cells in the squirrel monkey Saimiri sciureus: characterization and functional aspects of T lymphocytes. Res. Immunol. 140: 857.
9. GYSIN, J., S. PAUILLAC, and T. FANDEUR. 1987. Characterization by anti-Ig monoclonal antibodies of protective and non-protective antibodies against asexual forms of Plasmodium falciparum in the Saimiri monkey. Ann. Inst. Pasteur/Immunol. 138: 829.
10. GROUX, H., R. PERRAUT, O. GARRAUD, J. P. POINGT, and J. GYSIN. 1990. Identification of functional differences between protective and non protective anti-P. falciparum asexual blood stage antibodies in the Saimin sciureus. Eur. J. Immunol. 20: 2317.
11. PERRAUT, R., E. HUNDT, O. GARRAUD, B. ENDERS, and J. GYSIN. 1993. Comparison of the effects of adjuvants and adjuvant doses on the quantitative and qualitative antibody response to selected antigens in New World squirrel monkeys Saimiri sciureus. Vaccine 11: 730.
12. PERRAUT, R., A. R. LUSSOW, S. GAVOILLE, O. GARRAUD, H. MATILL, C. TOUGNE, J. VAN EMBDEN, R. VAN DER ZEE, P.-H. LAMBERT, J. GYSIN, and G. DEI GIUDICE. 1993. Successful primate immunization with peptides conjugated to purified protein derivative or mycobacterial heat shock proteins in the absence of adjuvants. Clin. Exp. Immunol. 93: 382.
13. DENNIS, V. A., R. LUJAN, W. L. J. CHAPMAN, and W. L. HANSON. 1986. Leishmania donovani: cellular and humoral immune responses after primary and challenge infections in squirrel monkeys, Saimiri sciureus. Exp. Parasit. 61: 319.
14. MILLER, G., T. SHOPE, H. LISCO, D. STITT, and M. LIPMAN. 1972. Epstein-Bar virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc. Natl. Acad. Sci. USA 69: 383.
15. PUNG, O. J., and R. E. KUHN. 1987. Experimental American leishmaniasis in the Brazilian squirrel monkey (Saimiri sciureus): lesions, hematology, cellular, and humoral immune responses. J. Med. Primatol. 16: 165.
16. PUNG, O. J., L. H. HUSELBOS, and R. E. KUHN. 1988. Experimental Chagas' disease (Trypanosoma cruzi) in the Brazilian squirrel monkey (Saimiri sciureus): hematology, cardiology, cellular and humoral immune responses. Int. J. Parasit. 18: 115.
17. GARRAUD, O., R. PERRAUT, J. GYSIN, C. BEHR, P. DUBOIS, B. BONNEMAINS, J. C. MICHEL, and L. PEREIRA DA SILVA. 1994. Manipulating blood T-cells and B-cells from squirrel monkeys: some technical considerations. J. Immunol. Methods 173: 165.
18. HAYGLASS, K. T., and B. P. STEFURA. 1991. Anti-interferon γ treatment blocks the ability of glutaraldehyde-polymerized allergens to inhibit specific IgE responses. J. Exp. Med. 173: 279.
19. GRUN, J. L., and P. H. MAURER. 1989. Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous Interleukin 1 in proliferative responses. Cell. Immunol. 121: 134.
20. DE WIT, D., M. V. MECHELEN, M. RYELANDT, A. C. FIGUEIREDO, D. ABRAMOWICZ, M. GOLDMAN, H. BAZIN, J. URBAIN, and O. LEO. 1992. The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T-helper type 1 but not type 2 lymphocytes. J. Exp. Med. 175: 9.
21. MA, J., P. A. BULGER, D. DAVIS, B. PERILLI-PALMER, D. A. BEDORE, C. R. KENSIL, E. M. YOUNG, C. H. HUNG, J. R. SEALS, C. S. PAVIA, and R. T. COUGHLIN. 1994. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OSpB of Borrelia burgdorferi. Vaccine 12: 925.
22. FINKELMAN, F. D., J. HOLMES, I. M. KATONA, J. F. J. URBAN, M. P. BECKMAN, L. S. PARK, K. A. SCHOOLEY, R. L. COFFMAN, T. R. MOSSMANN, and W. E. PAUL. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Ann. Rev. Immunol. 8: 303.
23. STEVENS, T. L., A. BOSSIE, V. M. SANDERS, R. FERNANDEZ-BOTRAN, R. L. COFFMAN, T. R. MOSMANN, and E. S. VITETTA. 1988. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334: 255.
24. GAJEWSKI, T. F., M. PINNAS, T. WONG, and F. W. FITCH. 1991. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J. Immunol. 146: 1750.
25. MORRIS, W., M. C. STEINHOFF, and P. K. RUSSELL. 1994. Potential of polymer microencapsulation technology for vaccine innovation. Vaccine 12: 5.
26. AGUADO, M. T., and P. H. LAMBERT. 1992. Controlled-release vaccines - biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles. Immunobiol. 184: 113.
27. ELDRIDGE, J. H., R. M. GILLEY, J. K. STAAS, Z. MOLDOVEANU, J. A. MEULBROEK, and T. R. TICE. 1989. Biodegradable microspheres: vaccine delivery system for oral administration. Curr. Top. Microbiol. Immunol. 146: 59.